Home > PS Ratio > ADVANCED ENZYME TECHNOLOGIES

ADVANCED ENZYME TECHNOLOGIES
PS (Price/Sales) Ratio

The Current P/S Ratio of ADVANCED ENZYME TECHNOLOGIES is 4.87.

Share Price ₹324.4Aug 07,2026
Market Cap ₹3,633.3 Cr
Sales-TTM₹745.8 CrTTM-Consolidated Results
Price/Sales4.87xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for ADVANCED ENZYME TECHNOLOGIES
Please provide your vote to see the results
ADVANCED ENZYME TECHNOLOGIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of ADVANCED ENZYME TECHNOLOGIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of ADVANCED ENZYME TECHNOLOGIES is calculated as :

Current Market Cap [ ₹3,633.3 Cr] as on Aug 07,2026

(/) Sales [ ₹745.8 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 4.87x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for ADVANCED ENZYME TECHNOLOGIES , the investors are currently willing to pay '4.87 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of ADVANCED ENZYME TECHNOLOGIES !

The chart below summarizes the trend in P/S Ratio of ADVANCED ENZYME TECHNOLOGIES over the last five years.

Historical PS (Price/Sales) ratio chart of ADVANCED ENZYME TECHNOLOGIES


PS Ratio Performance Analysis for ADVANCED ENZYME TECHNOLOGIES

- ADVANCED ENZYME TECHNOLOGIES 's latest p/e ratio is 4.87x.

- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 5.14x.

- ADVANCED ENZYME TECHNOLOGIES 's operated at median p/e ratio of 4.9x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, ADVANCED ENZYME TECHNOLOGIES 's p/e ratio peaked in Mar2024 at 6.23x.

- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio hit its five-year low in Mar2026 of 3.83x.


How does ADVANCED ENZYME TECHNOLOGIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
ADVANCED ENZYME TECHNOLOGIES 745.84.873,633.3
SUN PHARMACEUTICAL INDUSTRIES LTD59,910.57.81467,630.0
DIVIS LABORATORIES LTD11,230.019.50218,972.0
TORRENT PHARMACEUTICALS LTD15,723.011.98188,358.0
CIPLA LTD28,324.44.20118,916.0
DR REDDYS LABORATORIES LTD33,227.92.9497,824.0
MANKIND PHARMA LTD14,737.96.83100,730.0
LUPIN LTD29,966.63.60107,907.0
ZYDUS LIFESCIENCES LTD27,148.44.10111,242.0
AUROBINDO PHARMA LTD34,935.32.7495,570.3
LAURUS LABS LTD7,269.613.79100,228.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ADVANCED ENZYME TECHNOLOGIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.74x
Max industry PS 19.50x
Median industry PS 4.87x
Average industry PS 7.49x



You may also like the below Video Courses